If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

  • There is currently no data for JADE

Strategic partnership with MBM Limited

16 Aug 2024 15:10

RNS Number : 8150A
Jade Road Investments Limited
16 August 2024
 

Jade Road Investments Limited

16 August 2024

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE" or the "Company)

Strategic partnership with MBM Limited

Jade Road Investments Limited (AIM: JADE) is pleased to announce that it has entered into a strategic partnership with MBM Limited (MBM), pursuant to which MBM will both make potential investment introductions to Jade as well as providing it with new capital in the form of a convertible loan.

MBM provides comprehensive consultancy services designed to support companies in various aspects of growth and investment, including fundraising, marketing, deal sourcing, board strengthening and investor communication. With a collective experience of over 70 years, the expert team at MBM works closely with businesses, often taking equity stakes to align its performance with the goals of company owners and shareholders. This hands-on approach ensures that MBM not only delivers strategic guidance but also has a vested interest in the success and sustainability of the businesses it supports, fostering a collaborative environment that enhances overall performance and drives long-term value.

Jade will constitute up to £300,000 in principal value of convertible loan notes (CLN). The CLN is non-interest bearing, has a maturity of 10 months and is convertible at either MBM or the Company's option into JADE shares at a price which is 30% below the lowest closing bid price over the 30 business days prior to the date on which either party notifies the other it wishes to convert. Subject to agreement with MBM, Jade will issue tranches of the CLN to MBM, the first of which has been agreed in the sum of £80,000 and which will be paid for by MBM within 30 days of MBM being issued the Commission Shares referred to below.

MBM has agreed to take its commission for making successful investment introductions to Jade and investing in the CLN in the form of Jade shares. Accordingly, an initial 25,000,000 Jade shares have today been issued to MBM (Commission Shares)

Further announcements will be made in regard to CLN drawdowns will be made in due course.

The partnership is in its early stages, but initial discussions with several founders and management of new investment opportunities have already begun, each of whom are showing significant interest in partnering with the Company and accepting Jade shares in exchange for stakes in their businesses.

Further announcements will be released to update on further tranches of the CLN being issued to MBM as well as updates on target investment opportunities.

The board of Jade Road is excited about the prospects this partnership presents and looks forward to providing further updates in the near future.

Application will be made to AIM for Admission, which is expected to become effective and dealings in the initial tranche of 25,000,000 shares to commence at, 8.00 a.m. on or around 19 August 2024.

Following Admission, the total voting rights in the Company will therefore be 380,545,330 and Shareholders will be able to use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

 

 

For further information, please contact:

 

Jade Road Investments Limited

 

+44 (0) 778 531 5588

John Croft

 

Zeus Capital Limited - Nominated Adviser

 

+44 (0) 203 829 5000

James Joyce

 

Hybridan LLP - Nominated Broker

 

+44 (0) 20 3764 2341

Claire Louise Noyce

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRGPURURUPCGCQ
Date   Source Headline
28th Jun 20245:43 pmRNSFinal Results
29th May 20247:00 amRNSCompletion of the disposal of Legacy Assets
13th May 20247:00 amRNSUpdate on the disposal of Legacy Assets
1st May 20244:28 pmRNS2023 AGM Voting Results
8th Apr 20244:23 pmRNSPosting of Circular and Notice of AGM
3rd Apr 20243:58 pmRNSUpdates on Disposal of Legacy Assets
22nd Jan 20247:00 amRNSWebsite Update: Company Presentation and Q&A
5th Jan 20247:00 amRNSInvestor Meet Company Presentation
2nd Jan 20247:00 amRNSProposed Disposal of Legacy Assets & Restructuring
13th Dec 20237:00 amRNSOperational Update
15th Nov 20237:56 amRNSInvestment in Heirloom Litigation Finance
29th Sep 20237:00 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
4th Sep 20237:00 amRNSPlacement of Shares
25th Aug 202311:56 amRNSPlacement of shares
26th Jul 20232:10 pmRNSSecond Supplemental Bond Instrument Update
17th Jul 202311:37 amRNSUpdate on Interest Payment to Bondholders
3rd Jul 20235:45 pmRNSBond Interest Payment Update, Proposed Fundraising
26th May 20232:06 pmRNS2022 AGM Voting Results
26th May 20231:16 pmRNSFinal Results
9th May 20237:00 amRNSCorrection: Finding a Genuine Alternative
5th May 20231:57 pmRNSFinding a Genuine Alternative
5th Apr 20237:00 amRNSNew Investment
27th Mar 20237:00 amRNSRevision to Investment Management Agreement
24th Mar 202310:56 amRNSBoard Change
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20234:40 pmRNSSecond Price Monitoring Extn
6th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20237:00 amRNSResults of General Meeting
20th Feb 20237:00 amRNSCompletion of Conditional Equity Fundraise
31st Jan 20233:45 pmRNSReplacement Circular
31st Jan 20238:44 amRNSCirc re. Investing Policy, Proposed Placing & GM
1st Dec 202211:19 amRNSUS Dollar-denominated Corporate Bonds
21st Oct 20227:42 amRNSUS Dollar-denominated corporate bonds
22nd Sep 202211:59 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2022
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20222:28 pmRNSPartial Divestment in Meize Energy Industries
17th Aug 20229:05 amRNSSecond Price Monitoring Extn
17th Aug 20229:00 amRNSPrice Monitoring Extension
1st Aug 202211:05 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
20th Jul 20228:36 amRNSPartial Divestment in Meize Energy Industries
1st Jul 202210:29 amRNSReplacement for Final Results
30th Jun 20227:00 amRNSFinal Results
22nd Jun 20227:39 amRNSPartial divestment in Meize Energy Industries
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.